NICE Draft Guidance Gives People Living With Hepatitis C More Treatment Options
Monday, Oct. 18th 2010 6:32 AM
NICE is currently updating part of its guidance on the use of peginterferon alfa and ribavirin for the treatment of chronic hepatitis C. Reflecting changes in the licensed indications for peginterferon alfa, today’s draft guidance reaffirms the previous draft issued for public consultation in recommending wider use of these drugs, and, where appropriate, shorter treatment durations, for people with chronic hepatitis C.
Related posts:
- Laser teeth whitening is normally done in three 20-minute bleaching treatments. Laser teeth whitening is normally done in three 20-minute bleaching treatments....
- Share of Cost, Laser Teeth Whitening Share of Cost, Laser Teeth Whitening...
- SOC – What is Laser Teeth Whitening ? With laser teeth whitening treatments you are able to walk out of the dental office with your teeth a lot brighter. With laser bleaching, a barrier is put around the gums and a strong bleach is put on your teeth. A laser light is used to activate the bleach to make it work. A down […]...
- Orthodontic Treatment for Children, Advantages Go Far Beyond Cosmetics Orthodontic Treatment for Children, Advantages Go Far Beyond Cosmetics...
- The Benefits of Professional Teething Whitening. The Benefits of Professional Teething Whitening....
- How can young people have bad teeth. How can young people have bad teeth....
- Share of Cost, Seniors, Oral and Their Dental Health Care. Share of Cost, Seniors, Oral and Their Dental Health Care. ...
- Share of Cost, NICE Consults On Draft Recommendations For Psychosis With Co-Existing Substance Misuse NICE is currently developing a clinical guideline on the assessment and management of psychosis with co-existing substance misuse in adults and young people. As part of this process, draft recommendations have been published on the NICE website for public consultation. Psychosis is used to describe a group of severe mental health disorders characterised by the […]...
- Share of Cost, Medi-Cal, NICE Consults On Draft Guideline On Food Allergies In Children NICE has opened the consultation on its draft clinical guideline on the diagnosis and assessment of food allergies in children and young people. Its aim is to support GPs and other health professionals in primary care and community settings in recognising the signs and symptoms of food allergy, by giving clear recommendations on taking allergy-focussed […]...
- Share of Cost, Various Treatment Options For Gingivitis Share of Cost, Various Treatment Options For Gingivitis...
- Patients Living With Gerd Now Have A New Treatment Option For Improved And Sustained Symptom Relief Takeda is pleased to announce that DEXILANT™ (dexlansoprazole) is now available in Canada. DEXILANT is the first and only proton pump inhibitor (PPI) with a novel DUAL DELAYED RELEASE technology, which delivers two separate doses of medication at different times providing improved and sustained symptom relief throughout the day and night....
- Share of Cost, Statement from HHS Secretary Sebelius on the Administration for Community Living Share of Cost, Statement from HHS Secretary Sebelius on the Administration for Community Living...
- Share of Cost, Weak federal oversight endangers health and safety of assisted living residents Share of Cost, Weak federal oversight endangers health and safety of assisted living residents...
- SOC – Alternative Teeth Whitening Options Some families are considering alternative teeth whitening options instead of buying expensive commercial products. Some studies have suggested one can whiten their teeth buy combining 1 tablespoon of baking soda with 1/2 tablespoon of hydrogen peroxide in a small glass of water while brushing the teeth for 5 minutes with the mixture. Make sure you […]...
- Share of Cost, Expectations About Future Use Of Long-Term Services And Supports Vary By Current Living Arrangement Share of Cost, Expectations About Future Use Of Long-Term Services And Supports Vary By Current Living Arrangement...
Posted on Monday, Oct. 18th 2010 6:32 AM | by Share of Cost | in Share of Cost | No Comments »